Dr. Princess Imoukhuede from University of Illinois has developed a new quantitative receptor measurement approach for examining glioblastomas (GBM) heterogeneity. This...
Dr. Princess Imoukhuede from University of Illinois has developed a new quantitative receptor measurement approach for examining glioblastomas (GBM) heterogeneity. This approach is a paradigm shift in single-cell technologies: from gene-centric to proteomics. It provides never-before-seen insight into GBM heterogeneity that will ultimately enable more effective cancer treatment. It is a sensitive, quantitative approach that enables high-throughput measurements.
Dr. Li from the University of IL has developed PEG gel and PDMS networks that have mechanophore’s embedded in them and has developed a method of using Ultrasound technique...
Dr. Li from the University of IL has developed PEG gel and PDMS networks that have mechanophore’s embedded in them and has developed a method of using Ultrasound technique to activate the mechanophores. The invention would be useful for non-invasive procedures and allow for stimulation of neurons by illuminating the mechanophore with ultrasound waves.
